Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) EBIT: 2015-2024

Historic EBIT for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to -$114.9 million.

  • Anaptysbio's EBIT rose 252.50% to $34.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$28.7 million, marking a year-over-year increase of 80.55%. This contributed to the annual value of -$114.9 million for FY2024, which is 30.08% up from last year.
  • Anaptysbio's EBIT amounted to -$114.9 million in FY2024, which was up 30.08% from -$164.4 million recorded in FY2023.
  • In the past 5 years, Anaptysbio's EBIT ranged from a high of -$23.9 million in FY2020 and a low of -$164.4 million during FY2023.
  • Over the past 3 years, Anaptysbio's median EBIT value was -$115.2 million (recorded in 2022), while the average stood at -$131.5 million.
  • Its EBIT has fluctuated over the past 5 years, first soared by 77.77% in 2020, then crashed by 137.92% in 2021.
  • Yearly analysis of 5 years shows Anaptysbio's EBIT stood at -$23.9 million in 2020, then plummeted by 137.92% to -$56.8 million in 2021, then plummeted by 102.69% to -$115.2 million in 2022, then tumbled by 42.77% to -$164.4 million in 2023, then soared by 30.08% to -$114.9 million in 2024.